Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Intangibles (2024 - 2025)

Addex Therapeutics' Intangibles history spans 2 years, with the latest figure at $228148.3 for Q4 2025.

  • On a quarterly basis, Intangibles rose 209.61% to $228148.3 in Q4 2025 year-over-year; TTM through Dec 2025 was $228148.3, a 209.61% increase, with the full-year FY2025 number at $219935.1, up 205.66% from a year prior.
  • Intangibles came in at $228148.3 for Q4 2025, up from -$208154.2 in the prior quarter.
  • The five-year high for Intangibles was $228148.3 in Q4 2025, with the low at -$208154.2 in Q4 2024.